Stay updated on KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial

Sign up to get notified when there's something new on the KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the efficacy or safety data of KPI-121 0.25% ophthalmic suspension compared to placebo in subjects with dry eye disease.
    Difference
    0.1%
    Check dated 2024-06-06T14:24:52.000Z thumbnail image
  4. Check
    5 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying both inclusion and exclusion criteria for potential participants. Previously, no information was provided regarding the participation criteria.
    Difference
    13%
    Check dated 2024-05-22T21:24:12.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:40:19.000Z thumbnail image

Stay in the know with updates to KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial page.